Topic: Rsv

CBS News reports on the new Vaccine Advisory Committee's focus on the risks of the childhood vaccination schedule. The segment features a pediatrician defending the benefits of the RSV immunization for infants. The hosts criticize the news presentation for functioning as an "ad for the RSV vaccine" and discuss the history of thimerosal and the 1976 swine flu vaccine issues.

Media reports are highlighting a "quaddemic" of respiratory viruses affecting children, including RSV and the flu. Critics argue that these reports are designed to maintain a state of public fear and encourage continuous vaccination. The segment notes the use of terms like "kiddos" in medical reporting to soften the delivery of health warnings.

Health officials warn of a "quaddemic" involving the flu, COVID-19, RSV, and norovirus, leading to the return of mask mandates in some hospitals and cities like Chicago and Los Angeles. The hosts mock a news reporter's mispronunciation of norovirus as "neurovirus" and discuss the rise in severe pneumonia cases.

Health officials are using the term "quaddemic" to describe the simultaneous spike in flu, COVID, RSV, and norovirus cases this winter. Medical experts on Good Morning America and local news outlets are emphasizing vaccination, hand washing, and avoiding "loud talking" to prevent the spread of respiratory droplets. The messaging is criticized for being inconsistent regarding holiday travel and social behavior.

The BBC reports on the development of mRNA vaccines for Norovirus, traditionally known as the "24-hour bug." The hosts discuss the symptoms of the virus, including intense gastrointestinal distress, and note its recent branding as a major public health threat. Vaccination rates for the flu and COVID-19 are reportedly lower than desired, leading to increased media pressure for uptake.

The hosts question the sudden prominence of Respiratory Syncytial Virus (RSV) in news cycles, noting it was rarely mentioned a decade ago. In other pharmaceutical news, the Department of Justice has filed a lawsuit against CVS, alleging the pharmacy chain filled unlawful opioid prescriptions and violated the Controlled Substances Act over the past ten years.

Moderna abruptly halted its mRNA vaccine clinical trial for Respiratory Syncytial Virus (RSV) in children after data indicated the vaccine might worsen the disease. The FDA disclosed that vaccinated children in the trial experienced severe RSV at rates up to three times higher than the placebo group.

Hospitals in at least six states have reinstated indoor mask policies as the CDC reports high levels of COVID, flu, and RSV across 31 states. Health officials are urging vaccinations for the "triple virus threat" as hospitalizations reach their highest levels in a year.

The sudden prominence of RSV in public health messaging is linked to the development of new vaccines for the virus. The hosts revisit a 1960s study where an RSV vaccine caused enhanced respiratory disease in children, expressing skepticism about current mRNA-based treatments.

A new Pfizer promotional campaign features a grandmother sharing her experience with RSV (Respiratory Syncytial Virus) to encourage vaccination among seniors. The ad emphasizes the risk of grandparents catching the virus from their grandchildren, a marketing tactic criticized as fear-based.

The CDC reports high levels of respiratory illness activity across 15 states and New York City as holiday travel increases. Health officials are tracking the JN1 COVID-19 sub-variant, which accounts for 20% of current cases, while emphasizing the importance of seasonal vaccinations.

The World Health Organization has requested data from China regarding a surge in respiratory illnesses and "undiagnosed pneumonia" in children. Hospitals in Beijing and Tianjin are reportedly overwhelmed, with some facilities seeing 13,000 patients a day. While Chinese officials attribute the spike to known pathogens like RSV and influenza, the timing has drawn comparisons to the early stages of the COVID-19 pandemic.

New CDC Director Dr. Mandy Cohen appeared on the Today show to urge Americans to get updated COVID-19, flu, and RSV vaccinations before holiday gatherings. The hosts criticize her "marketing" approach and the agency's attempt to rebuild trust through transparency. The segment highlights the continued push for vaccines despite public fatigue and skepticism regarding their effectiveness in stopping transmission.

A "boots on the ground" report from a physician in the Netherlands describes a Pfizer-sponsored lunch aimed at raising awareness for RSV vaccines. The report notes that while RSV is common in infants, it is rarely a cause for hospitalization in the elderly, yet it is being marketed to seniors to "gouge" government healthcare systems. The hosts discuss the financial incentives for doctors to push unnecessary shots to Medicare recipients.

CDC Director Dr. Mandy Cohen issues a holiday message urging Americans to get updated COVID-19, flu, and RSV vaccines before Thanksgiving. The hosts compare the "updated" vaccine marketing to software updates for Windows or iPhones. They also play an older clip of Keith Olbermann aggressively criticizing those who are "vaccine hesitant."

The hosts analyze a CBS News report on the "unprecedented demand" for RSV antibody shots, characterizing it as a "native ad" designed to create scarcity. They highlight a massive discrepancy in death statistics: the CDC reports 100-300 annual child deaths from RSV, while the Gates Foundation and CNN claim over 100,000. They suggest financial interests are driving the hype.

Pfizer CEO Albert Bourla appeared on CNBC's "Mad Money" to discuss the company's earnings. He attributed lower COVID-19 vaccine uptake to "vaccine fatigue" and "anti-vaxxer rhetoric," while Jim Cramer expressed confusion over why more people are not following his lead in getting boosted.

"Boots on the ground" reports from medical professionals suggest the widely reported shortage of RSV vaccines is a manufactured narrative to drive demand. Doctors indicate that insurance companies are refusing to cover the $1,000 shots because the risk to healthy adults is statistically negligible. The conflict appears to be a financial dispute between pharmaceutical manufacturers and insurers.

The CDC has updated recommendations for RSV shots due to supply shortages, prioritizing high-risk infants. Simultaneously, legal experts discuss potential lawsuits against Pfizer regarding alleged DNA fragment contamination in COVID-19 vaccines. The discussion compares the potential liability to the Johns Mansville asbestos litigation, suggesting Pfizer's corporate stability could be at risk.

The CDC and FDA have approved new Pfizer vaccines and monoclonal antibody treatments for RSV, targeting pregnant women and "neonates" (newborns). Media coverage emphasizes a 57% reduction in hospitalization risk for infants. The marketing of these treatments is criticized for treating seasonal illnesses as pharmaceutical sales opportunities.